Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

1.

Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer.

Rodriguez BA, Cheng AS, Yan PS, Potter D, Agosto-Perez FJ, Shapiro CL, Huang TH.

Carcinogenesis. 2008 Jul;29(7):1459-65. doi: 10.1093/carcin/bgn115. Epub 2008 May 21.

PMID:
18499701
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer.

Wang Z, Dahiya S, Provencher H, Muir B, Carney E, Coser K, Shioda T, Ma XJ, Sgroi DC.

Clin Cancer Res. 2007 Nov 1;13(21):6327-34.

PMID:
17975144
[PubMed - indexed for MEDLINE]
Free Article
3.

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer.

Ma XJ, Hilsenbeck SG, Wang W, Ding L, Sgroi DC, Bender RA, Osborne CK, Allred DC, Erlander MG.

J Clin Oncol. 2006 Oct 1;24(28):4611-9.

PMID:
17008703
[PubMed - indexed for MEDLINE]
4.

HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study.

Jansen MP, Sieuwerts AM, Look MP, Ritstier K, Meijer-van Gelder ME, van Staveren IL, Klijn JG, Foekens JA, Berns EM.

J Clin Oncol. 2007 Feb 20;25(6):662-8.

PMID:
17308270
[PubMed - indexed for MEDLINE]
5.

Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.

Han Y, Yang L, Suarez-Saiz F, San-Marina S, Cui J, Minden MD.

Mol Cancer Res. 2008 Aug;6(8):1347-55. doi: 10.1158/1541-7786.MCR-07-2179.

PMID:
18708366
[PubMed - indexed for MEDLINE]
Free Article
6.

Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.

Badia E, Duchesne MJ, Semlali A, Fuentes M, Giamarchi C, Richard-Foy H, Nicolas JC, Pons M.

Cancer Res. 2000 Aug 1;60(15):4130-8.

PMID:
10945620
[PubMed - indexed for MEDLINE]
Free Article
7.

Exploring the two-gene ratio in breast cancer--independent roles for HOXB13 and IL17BR in prediction of clinical outcome.

Jerevall PL, Brommesson S, Strand C, Gruvberger-Saal S, Malmström P, Nordenskjöld B, Wingren S, Söderkvist P, Fernö M, Stål O.

Breast Cancer Res Treat. 2008 Jan;107(2):225-34. Epub 2007 Apr 24.

PMID:
17453342
[PubMed - indexed for MEDLINE]
8.

HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ERα and inducing IL-6 expression.

Shah N, Jin K, Cruz LA, Park S, Sadik H, Cho S, Goswami CP, Nakshatri H, Gupta R, Chang HY, Zhang Z, Cimino-Mathews A, Cope L, Umbricht C, Sukumar S.

Cancer Res. 2013 Sep 1;73(17):5449-58. doi: 10.1158/0008-5472.CAN-13-1178. Epub 2013 Jul 5.

PMID:
23832664
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.

Putnik M, Zhao C, Gustafsson JÅ, Dahlman-Wright K.

Biochem Biophys Res Commun. 2012 Sep 14;426(1):26-32. doi: 10.1016/j.bbrc.2012.08.007. Epub 2012 Aug 10.

PMID:
22902638
[PubMed - indexed for MEDLINE]
10.

Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.

Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.

Cancer Res. 2002 Sep 1;62(17):4977-84.

PMID:
12208749
[PubMed - indexed for MEDLINE]
Free Article
11.

[Study of the CpG methylation status of ER alpha gene in estrogen receptor alpha-negative breast cancer cell lines and the role of hydralazine demethylation].

Tang B, Jiang J.

Zhonghua Bing Li Xue Za Zhi. 2005 May;34(5):283-7. Chinese.

PMID:
16181550
[PubMed - indexed for MEDLINE]
12.

A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen.

Goetz MP, Suman VJ, Ingle JN, Nibbe AM, Visscher DW, Reynolds CA, Lingle WL, Erlander M, Ma XJ, Sgroi DC, Perez EA, Couch FJ.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2080-7.

PMID:
16609019
[PubMed - indexed for MEDLINE]
Free Article
13.

Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells.

Ford CE, Ekström EJ, Andersson T.

Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3919-24. doi: 10.1073/pnas.0809516106. Epub 2009 Feb 23. Retraction in: Ford CE, Ekström EJ, Anderson T. Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22360.

PMID:
19237581
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells.

Fleury L, Gerus M, Lavigne AC, Richard-Foy H, Bystricky K.

Oncogene. 2008 Jul 3;27(29):4075-85. doi: 10.1038/onc.2008.41. Epub 2008 Mar 3.

PMID:
18317449
[PubMed - indexed for MEDLINE]
15.

CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.

Ramezani F, Salami S, Omrani MD, Maleki D.

Asian Pac J Cancer Prev. 2012;13(2):451-7.

PMID:
22524805
[PubMed - indexed for MEDLINE]
Free Article
16.

Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance.

Goetz MP, Suman VJ, Couch FJ, Ames MM, Rae JM, Erlander MG, Ma XJ, Sgroi DC, Reynolds CA, Lingle WL, Weinshilboum RM, Flockhart DA, Desta Z, Perez EA, Ingle JN.

Clin Cancer Res. 2008 Sep 15;14(18):5864-8. doi: 10.1158/1078-0432.CCR-08-0619.

PMID:
18794098
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Silencing of estrogen receptor alpha (ERalpha) gene by promoter hypermethylation is a frequent event in Chinese women with sporadic breast cancer.

Zhao L, Wang L, Jin F, Ma W, Ren J, Wen X, He M, Sun M, Tang H, Wei M.

Breast Cancer Res Treat. 2009 Sep;117(2):253-9. doi: 10.1007/s10549-008-0192-1. Epub 2008 Sep 24.

PMID:
18814026
[PubMed - indexed for MEDLINE]
18.

Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer.

Jerevall PL, Jansson A, Fornander T, Skoog L, Nordenskjöld B, Stål O.

Breast Cancer Res. 2010;12(4):R53. doi: 10.1186/bcr2612. Epub 2010 Jul 22.

PMID:
20649975
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant.

Fan M, Yan PS, Hartman-Frey C, Chen L, Paik H, Oyer SL, Salisbury JD, Cheng AS, Li L, Abbosh PH, Huang TH, Nephew KP.

Cancer Res. 2006 Dec 15;66(24):11954-66.

PMID:
17178894
[PubMed - indexed for MEDLINE]
Free Article
20.

Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer.

Tommasi S, Karm DL, Wu X, Yen Y, Pfeifer GP.

Breast Cancer Res. 2009;11(1):R14. doi: 10.1186/bcr2233. Epub 2009 Feb 27.

PMID:
19250546
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk